RESEARCHER PROFILE
Remco Nagel
R
Oncode Institute
Remco Nagel works in Cancer-related Molecular Pathways, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, FOXO transcription factor regulation, Cancer Mechanisms and Therapy. Recorded institutional associations include The Netherlands Cancer Institute, Oncode Institute.
122Publications
5,898Citations
21H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
2006 · 1,264 citationsThe microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
2008 · 975 citationsRegulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
2007 · 815 citationsRNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA
2007 · 732 citationsRegulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer
2008 · 474 citationsOrigins, genetic landscape, and emerging therapies of small cell lung cancer
2015 · 250 citationsA Genetic Screen Implicates miRNA-372 and miRNA-373 as Oncogenes in Testicular Germ Cell Tumors
2007 · 170 citationsAnti-tumour immunity induces aberrant peptide presentation in melanoma
2020 · 161 citationsDrugging the addict: non‐oncogene addiction as a target for cancer therapy
2016 · 151 citationsTryptophan depletion results in tryptophan-to-phenylalanine substitutants
2022 · 148 citationsThe miRNA‐192/194 cluster regulates the Period gene family and the circadian clock
2009 · 124 citationsTreatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines
2013 · 79 citationsFunctional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer
2013 · 77 citationsSLC1A3 contributes to L‐asparaginase resistance in solid tumors
2019 · 71 citationsProteomic patterns associated with response to breast cancer neoadjuvant treatment
2020 · 66 citationsDiverse Ways to Control p27Kip1 Function: miRNAs Come into Play
2007 · 62 citationsOncogene-dependent sloppiness in mRNA translation
2021 · 61 citationsGenome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2015 · 37 citationsInhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2019 · 36 citationsProteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction
2019 · 34 citationsA comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
2021 · 24 citationsSlippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting
2022 · 21 citationsBoosting Antitumor Immunity with an Expanded Neoepitope Landscape
2022 · 18 citationsAdoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
2025 · 17 citationsCUEDC1 is a primary target of ERα essential for the growth of breast cancer cells
2018 · 12 citations
